Intracellular dehydrogenases in living cells reduce WST-8 to an orange formazan product. The amount of this product produces an absorbance signal at approximately 450 nm, which correlates with the number of metabolically active cells. In neuronal cultures, this relationship allows researchers to compare cellular activity after exposure to drugs, stressors, or potentially neurotoxic conditions.
A higher absorbance near 450 nm generally indicates a greater amount of metabolically active cellular material, whereas a lower reading indicates less activity under the tested conditions. Because the assay measures a metabolic signal rather than providing a direct visual cell count, researchers interpret the result as an estimate of viability or proliferation and compare it across experimental treatments.
WST-8 provides the chemical substrate that links intracellular dehydrogenase activity to a visible color change. Its reduction by living cells generates water-soluble orange formazan, allowing the signal to be measured colorimetrically. This reaction supports quantitative assessment without requiring a radioactive readout, which is useful when studying treatment-dependent changes in neuronal cultures.
Researchers expose cultured neurons or neural cell lines to the experimental condition, allow the cellular dehydrogenase reaction with WST-8 to generate formazan, and measure absorbance at approximately 450 nm. Comparing readings between conditions provides a quantitative way to evaluate how drugs, stressors, or suspected neurotoxic treatments affect metabolically active cells.
The method is useful when an experiment asks whether a treatment changes neuronal health, survival, or cellular proliferation. Neuroscientists can apply it to evaluate neurotoxicity, examine neuronal responses to drugs, and assess effects of cellular stressors. Results help compare treatment groups through a nonradioactive, quantitative measurement of metabolically active cells.
A neurotoxicity experiment can use absorbance differences to compare the relative metabolic activity of treated and untreated neuronal cultures or neural cell lines. Reduced signal may indicate fewer metabolically active cells under a treatment, while increased signal may reflect greater activity or proliferation. The assay therefore supports quantitative comparisons of treatment effects, rather than describing specific cellular damage mechanisms.